The benefits of short-term hormone replacement therapy likely outweigh the risks for younger women, the Ohio-based North American Menopause Society said.
The society issued a new position statement on hormone therapy that will be published in its journal, Menopause. The society said the risks and benefits of hormone therapy change as a woman ages.
In an example cited in Friday's Wall Street Journal, women 20 years past menopause and taking hormones had a 71 percent higher risk of a heart attack, while women closer to menopause had an 11 percent lower risk, the Wall Street Journal said.
The newspaper said that hormones are still only recommended for short-term treatment of menopausal symptoms.
Nearly five years ago, the Women's Health Initiative study was stopped early because older participants suffered a high rate of heart attacks.
"I think these guidelines help to put the recent evidence and the new studies into perspective for women," Harvard researcher JoAnn Manson, who worked on both that study and the new guidelines, told the Wall Street Journal. "I think the statement is likely to be reassuring to them that with short-term use the benefits of hormones are likely to outweigh the risks."
Copyright 2007 by United Press International
Related stories:
Too much, too little sleep increases ischemic risk in postmenopausal women
Postmenopausal women who regularly sleep more than nine hours a night may have an increased risk of ischemic stroke, researchers reported in Stroke: Journal of the American Heart Association.
Why men are more at risk of diseases caused by blood clots than women
Being male increases your risk of diseases caused by the inappropriate formation of a blood clot (a process known as thrombosis), such as heart attack and stroke, but the reasons for this are not completely understood. However, Ethan Weiss and colleagues at the University of California, San Francisco, have used a mouse model of thrombosis to shed new light on this matter.
Sleep problems associated with menopause vary among ethnic groups
Difficulty falling asleep and staying asleep increase as women go through menopause according to research by Rush University Medical Center. Waking up earlier than planned also increases through late perimenopause but decreases when women become postmenopausal. The study is published in the July 1 issue of the journal
SLEEP.
Homosexual behaviour due to genetics and environmental factors
Homosexual behaviour is largely shaped by genetics and random environmental factors, according to findings from the world’s largest study of twins.
Homosexual behavior due to genetics and environmental factors
Homosexual behaviour is largely shaped by genetics and random environmental factors, according to findings from the world's largest study of twins.
Pregnancy may help protect against bladder cancer
Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found. Female mice that had never become pregnant had approximately 15 times as much cancer in their bladders as their counterparts that had become pregnant, according to new findings by investigators at the University of Rochester Medical Center.
New study: Pine bark significantly reduces menstrual pain
A new study reveals dysmenorrhea, a condition that causes extremely painful menstrual periods affecting millions of women each year, can be reduced naturally by taking Pycnogenol (pic-noj-en-all), pine bark extract from the French maritime pine tree. The multi-center field study, published in the
Journal of Reproductive Medicine, shows women with dysmenorrhea who supplemented with Pycnogenol experienced less pain and required less pain medications during menstruation.
Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women
New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Women who took the drug raloxifene were less likely to develop invasive, estrogen-receptor (ER) positive breast cancer compared with women who did not take the drug. The results of the randomized controlled trial will be published in the June 10 online issue of the
Journal of the National Cancer Institute.